These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7998105)

  • 1. Effects of interleukin-10 on the immunoactivating and immunosuppressive properties of anti-CD3 monoclonal antibody.
    Wissing M; Donckier V; Delvaux A; Abramowicz D; Gérard C; Velu T; Goldman M
    Transplant Proc; 1994 Dec; 26(6):3167-8. PubMed ID: 7998105
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-10 eliminates anti-CD3 monoclonal antibody-induced mortality and prolongs heart allograft survival in inbred mice.
    Lowry RP; Konieczny B; Alexander D; Larsen C; Pearson T; Smith S; Narula S
    Transplant Proc; 1995 Feb; 27(1):392-4. PubMed ID: 7879034
    [No Abstract]   [Full Text] [Related]  

  • 3. A rat anti-mouse CD3 monoclonal antibody induces long-term skin allograft survival without inducing side effects.
    Vossen AC; Tibbe GJ; van Oudenaren A; Vredendaal AE; Benner R; Savelkoul HF
    Transplant Proc; 1994 Dec; 26(6):3157-8. PubMed ID: 7998101
    [No Abstract]   [Full Text] [Related]  

  • 4. Involvement of tumor necrosis factor in development of anti-CD3 monoclonal antibody induced pulmonary edema.
    Nakajima F; Nakamura H; Stenzel KH; Suthanthiran M
    Transplant Proc; 1994 Aug; 26(4):1939-40. PubMed ID: 8066628
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
    Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
    Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of Th2-like cells after anti-CD3 monoclonal antibody administration in mice.
    Wissing M; Alegre ML; Abramowicz D; Willems F; Donckier V; Vanderhaeghen ML; Leo O; Goldman M
    Transplant Proc; 1995 Feb; 27(1):378-9. PubMed ID: 7879027
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of an anti-CD3 priming dose to enhance the immunosuppressive potency of monoclonal and polyclonal T-cell antisera.
    Sherburne CG; Onyekaba CO; Condie RM
    Transplant Proc; 1991 Feb; 23(1 Pt 1):626-9. PubMed ID: 1824996
    [No Abstract]   [Full Text] [Related]  

  • 8. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
    J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo induction of IL-10 by anti-CD3 monoclonal antibody in mice.
    Velu T; Durez P; Van Mechelen M; Gérard C; Abramowicz D; Moser M; Leo O; Goldman M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):568-9. PubMed ID: 8438417
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study on the improved effect of anti-TCR alpha beta monoclonal antibody on the induction of transplantation tolerance to the allogeneic skin graft in mice and its mechanisms].
    Hao J; Liu J; Xie S
    Zhonghua Yi Xue Za Zhi; 2001 May; 81(10):593-6. PubMed ID: 11798930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance induction by anti-CD2 plus anti-CD3 monoclonal antibodies: evidence for an IL-4 requirement.
    Punch JD; Tono T; Qin L; Bishop DK; Bromberg JS
    J Immunol; 1998 Aug; 161(3):1156-62. PubMed ID: 9686574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model.
    Jeyarajah DR; Schmeisser FS; Josephson MA; Sohn DG; Thistlethwaite JR
    Transplant Proc; 1994 Apr; 26(2):771-3. PubMed ID: 8171656
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation.
    Pearson TC; Hamano K; Morris PJ; Wood KJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):786-7. PubMed ID: 8438480
    [No Abstract]   [Full Text] [Related]  

  • 14. Devising murine models to better adapt clinical protocols: sequential low-dose treatment with anti-CD3 and anti-CD4 monoclonal antibodies to prevent fully mismatched allograft rejection.
    Campos HH; Bach JF; Chatenoud L
    Transplant Proc; 1993 Feb; 25(1 Pt 1):798-9. PubMed ID: 8438486
    [No Abstract]   [Full Text] [Related]  

  • 15. Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments.
    Chen Z; Cobbold S; Waldmann H; Metcalfe S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):790-1. PubMed ID: 8438482
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of exogenous IL-2 on tolerance induction by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
    Isobe M; Suzuki J; Yamazaki S; Sekiguchi M
    Transplant Proc; 1996 Apr; 28(2):1045-6. PubMed ID: 8623222
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of the release of cytokines and reduction of the shock syndrome induced by anti-CD3 monoclonal antibody in mice by interleukin-10.
    Donckier V; Flament V; Gérard C; Abramowicz D; Vandenabeele P; Wissing M; Delvaux A; Fiers W; Leo O; Velu T
    Transplantation; 1994 May; 57(10):1436-9. PubMed ID: 8197603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged survival of mouse cardiac allografts after CD4 or CD8 monoclonal antibody therapy is associated with selective intragraft cytokine protein expression: interleukin (IL)-4 and IL-10 but not IL-2 or interferon-gamma.
    Hancock W; Mottram PL; Purcell LJ; Han WR; Pietersz GA; McKenzie IF
    Transplant Proc; 1993 Oct; 25(5):2937-8. PubMed ID: 8212290
    [No Abstract]   [Full Text] [Related]  

  • 19. Down-regulation of interleukin-2 and interferon-gamma and maintenance of interleukin-4 and interleukin-10 production after administration of an anti-CD3 monoclonal antibody in mice.
    Wissing KM; Desalle F; Abramowicz D; Willems F; Leo O; Goldman M; Alegre ML
    Transplantation; 1999 Sep; 68(5):677-84. PubMed ID: 10507488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine production.
    Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
    Transplant Proc; 1993 Feb; 25(1 Pt 1):823-4. PubMed ID: 8094913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.